Net Cash Provided by (Used in) Operating Activities |
1.33M |
USD |
-41.4% |
Q3 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
1.22M |
USD |
|
Q3 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-755K |
USD |
+53.7% |
Q3 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
750K |
shares |
0% |
Q2 2024 |
FY 2024 |
Common Stock, Shares, Issued |
734K |
shares |
0% |
Q2 2024 |
FY 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
1.8M |
USD |
+6093% |
Q3 2023 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
1.61M |
USD |
-22.1% |
Q3 2023 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
36.3M |
USD |
+7.57% |
Q2 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
36.3M |
USD |
+7.57% |
Q2 2024 |
FY 2024 |
Depreciation |
821K |
USD |
+30.9% |
Q3 2023 |
Q1 2024 |
Payments to Acquire Property, Plant, and Equipment |
755K |
USD |
-53.7% |
Q3 2023 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
-3K |
USD |
+99.6% |
Q3 2022 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
14.4M |
USD |
+9.84% |
Q2 2024 |
FY 2024 |
Unrecognized Tax Benefits |
1.67M |
USD |
0% |
Q2 2024 |
FY 2024 |
Depreciation, Depletion and Amortization |
546K |
USD |
+19% |
Q3 2022 |
Q1 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
8.41M |
USD |
-38.3% |
Q2 2022 |
FY 2023 |